Thyroid Cancer Following Exposure to Radioactive Iodine

Reviews in Endocrine and Metabolic Disorders

Volumn 1, Issue 3, 2000, Pages 197-203

  Robbins, Jacob ^a   Schneider, Arthur B ^b  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Chernobyl; Epidemiology; Radiation related; Radioactive iodine; Thyroid cancer

Indexed keywords

DIAGNOSTIC AGENT; RADIOACTIVE IODINE;

ATOMIC WARFARE; HUMAN; RADIATION ACCIDENT; RADIATION INJURY; RADIOACTIVE WASTE; REVIEW; THYROID TUMOR;

ACCIDENTS, RADIATION; HUMANS; IODINE RADIOISOTOPES; NEOPLASMS, RADIATION-INDUCED; NUCLEAR WARFARE; RADIOACTIVE FALLOUT; THYROID NEOPLASMS;

EID: 0034173026     PISSN: 13899155     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1010031115233     Document Type: Article

References (57)

1. Dobyns BM, Sheline GE, Workman JB, Tompkins EA, McConahey WM, Becker DV. Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism, A report of the Cooperative Thyrotoxicosis Therapy Study. J Clin Endocrinol Metab 1974;38:976-998.
2. Holm L-E, Hall P, Wiklund K, et al. Cancer risk after iodine-131 therapy for hyperthyroidism. J Natl Cancer Inst 1991;83:1072-1077.
3. Hall P, Berg G, Bjelkengren G, et al. Cancer mortality after iodine-131 therapy for hyperthyroidism. Int J Cancer 1992;50:886-890.
4. Hall P Lundell G, Holm L-E. Mortality in patients treated for hyperthyroidism with iodine-131. Acta Endocrinol 1993;128:230-234.
5. Ron E, Doddy MM, Becker DV, et al. Cancer mortality following treatment for adult hyperthyroidism. JAMA 1998;280:347-355.
6. Maxon HR, Saenger EL. Biological effects of radioiodines on the human thyroid gland. In: Braverman LE, Utiger R. eds Werner and Ingbar's The Thyroid. Philadelphia: Lippincott-Raven, 1996;343-351.
7. Franklyn JA, Maisonneuve P, Sheppard M, Bettendge J, Boyle P. Cancer incidence and mortality after radioiodine treatment for hyperthyroidism a population-based cohort study. Lancet 1993;353:2111-2115.
8. Shore RE. Issues and epidemiological evidence regarding radiation-induced thyroid cancer. Radiat Res 1992;131:98-111.
9. Ron E, Lubin JH, Shore RE, et al. Thyroid cancer after exposure to external radiation: A pooled analysis of seven studies. Radiat Res 1995;141:259-277.
10. Clark JD, Gelfand MJ, Elgazzar AH. Iodine-131 therapy of hyperthyroidism in pediatric patients. J Nucl Med 1995;36:442-445.
11. Hall P, Mattsson A, Boice JD Jr. Thyroid cancer after diagnostic administration of iodine-131. Radiat Res 1996;145:86-92.
12. Hall P, Furst CJ, Mattsson A, Holm L-E, Boice JD Jr. Inskip PD. Thyroid nodularity after diagnostic administration of iodine-131. Radiat Res 1996;146:673-682.
13. Dreicer M, Aarkog A, Alexakhin L, Anspaugh L, Arkhipov NP, Johansson K-J. Consequences of the Chernobyl Accident for the Natural and Human Environment. In: One Decade After Chernobyl Summing Up the Consequences of the Accident. Vienna: International Atomic Energy Agency, 1996;319-361.
14. Royal HD. The Three Mile Island and Chernobyl Reactor Accidents. In: Mettler FA, Jr. Kelsey CA, Ricks RC, eds Medical Management of Radiation Accidents. Boca Raton, FL: CRC Press, 1990;269-292.
15. Malone J, Unger J, Delange F, Lagasse R, Dumont JE. Thyroid consequences of Chernobyl accident in the countries of the European Community. J Endocrinol Invest 1991;14:701-717.
16. Straume T, Marchetti AA, Anspaugh LR, et al. The feasibility of using 1-129 to reconstruct 1-131 deposition from the Chernobyl reactor accident. Health Phys 1996;71:733-740.
17. Gavrilin YI, Khrouch VT, Shinkarev SM, et al. Chernobyl accident Reconstruction of thyroid dose for inhabitants of the Republic of Belarus. Health Phys 1999;76:105-119.
18. 131I vs short-lived nuclides. In: Thomas G, Karaoglou A, Williams ED. eds. Radiation and Thyroid Cancer. Singapore: World Scientific, 1999;195-199.
19. Jacob P, Goulko G, Heidenreich WF, et al. Thyroid cancer risk to children calculated. Nature 1998;392:31-32.
20. Becker DV, Robbins J, Beebe GW, Bouville AC, Wachholz BW. Childhood thyroid cancer following the Chernobyl accident, A status report. Endocrinol Metab Clin North Am 1996;25:197-211.
21. Astakhova LN, Anspaugh LR, Beebe GW, et al. Chernobyl-related thyroid cancer in children of Belarus. A case-control study. Radiat Res 1998;150:349-356.
22. Minenko V, Shemyakina E, Drozdovitch V, et al. Estimation of individual thyroid doses received by the subjects of the cohort screened in the Belarusian-American study. In: Thomas G, Karaoglou A, Williams ED, eds Radiation and Thyroid Cancer. Singapore: World Scientific, 1999;309-318.
23. Gembicki M, Stozharov AN, Arinchin AN, et al. Iodine deficiency in Belarusian children as a possible factor stimulating the irradiation of the thyroid gland during the Chernobyl catastrophe. Environ Health Perspect 1997;105:1487-1490.
24. Wachholz BW. United States cooperation with Belarus and Ukraine in the development and implementation of scientific protocols of thyroid cancer and other thyroid disease following the Chernobyl accident. In: Nagataki S, ed Nagasaki Symposium on Chernobyl Update and Future. Amsterdam: Elsevier, 1994;145-148.
25. Karaoglou A, Desmet G, Kelly GN, Menzel HG. Proceedings of the First International Conference. The Radiological Consequences of the Chernobyl Accident Publication EUR 16544, Brussels: European Communities, 1996.
26. Schwenn MR, Brill AB. Childhood cancer 10 years after the Chernobyl accident. Curr Opinion Pediatr 1997;9:51-54.
27. Sobolev B, Heidenreich WF, Kairo I, Jacob KP, Goulko G, Likhtarev I. Thyroid cancer incidence in the Ukraine after the Chernobyl accident: comparison with spontaneous incidences. Radiat Environ Biophys 1997;36:195-199.
28. Karaoglou A, Chadwick KH. Health consequences of Chernobyl and other radiation accidents - Report on the European Union Cluster Contractors' workshop (San Miniato, Italy, 17-22 June 1997). Radiat Environ Biophys 1998;37:1-9.
29. Thomas G, Karaoglou A, Williams ED. Radiation and Thyroid Cancer. Singapore: World Scientific, 1999.
30. Williams ED, Tronko ND. Molecular, Cellular, Biological Characterization of Childhood Thyroid Cancer. International Scientific Collaboration on Consequences of Chernobyl Accident, Luxembourg: European Commission, 1996.
31. Robbins J. Characteristics of spontaneous and radiation induced thyroid cancers in children. In: Nagataki S, ed Nagasaki Symposium on Chernobyl Update and Future. Amsterdam: Elsevier, 1994;81-87.
32. Williams ED, Cherstvoy ED, Egloff B, et al. Interaction of Pathology and Molecular Characterization of Thyroid Cancers. In: Karaoglou A, Desmet G, Kelly GN, Menzel HG, eds The Radiological Consequences of the Chernobyl Accident. Proceedings of the First International Conference, Minsk, Belarus, March 18-22, 1996 Publication EUR 16544 EN, Luxembourg: European Commission, 1996;699-715.
33. Robbins J, Schneider AB. Radioiodine-induced thyroid cancer. Studies in the aftermath of the accident at Chernobyl. Trends Endocrinol Metab 1998;9:87-94.
34. Nikiforov YE, Rowland JM, Bove KE, Monforte-Munoz H, Fagin JA. Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children. Cancer Res 1997;57:1690-1694.
35. Schneider AB, Ron E, Lubin J, Stovall M, Gierlowski TC. Dose-response relationships for radiation-induced thyroid cancer and thyroid nodules. Evidence for the prolonged effects of radiation on the thyroid. J Clin Endocrinol Metab 1993;77:362-369.
36. Conard RA. Late radiation effects in Marshall Islanders exposed to fallout 28 years ago. In: Boice JD, Jr., Fraumeni JR, eds Radiation carcinogenesis. Epidemiology and biological significance, New York: Raven Press, 1984;57-71.
37. Robbins J, Adams WH. Radiation effects in the Marshall Islands. In: Nagataki S, ed. Radiation and the thyroid. Amsterdam: Excerpta Medica, 1989;11-24.
38. Lessard E, Miltenberger RP, Cohn SH, Musolino SV, Conard RA. Protracted exposure to fallout. The Rongelap and Utenk experience. Health Phys 1984;46:511-527.
39. Shipler DB, Napier BA, Farris WT, Freshley MD. Hanford environmental dose reconstruction project: an overview. Health Phys 1996;71:532-544.
40. Farris WT, Napier BA, Ikenberry TA, Shipler DB. Radiation doses from Hanford Site releases to the atmosphere and the Columbia River. Health Phys 1996;71:588-601.
41. Davis S, Kopecky KJ, Hamilton T, Amundson B, Myers PA. Summary Final Report of the Hanford Thyroid Disease Study. Seattle: Fred Hutchinson Cancer Research Center 1999.
42. National Cancer Institute. Estimated Exposures and Thyroid Doses Received by the American People From I-131 in Fallout Following Nevada Atmospheric Nuclear Bomb Tests Bethesda, MD: National Institutes of Health, 1997.
43. Kerber RA, Till JE, Simon SL, et al. A cohort study of thyroid disease in relation to fallout from nuclear weapons testing. JAMA 1993;270:2076-2082.
44. Till JE, Simon SL, Kerber R, et al. The Utah thyroid cohort study. Analysis of the dosimetry results. Health Phys 1995;68:472-483.
45. Rallison ML, Dobyns BM, Keating FR Jr., Rail JE, Tyler FH. Thyroid disease in children. A survey of subjects potentially exposed to fallout radiation. JAMA 1974;56:457-463.
46. Boice JD Jr., Land CE, Preston DL. Ionizing Radiation. In: Schottenfeld D, Fraumeni, Jr. JF, eds Cancer Epidemiology and Prevention. New York: Oxford University Press, 1996;319-354.
47. Schneider AB, Robbins J. Ionizing radiation and thyroid cancer. In: Fagin J, ed Thyroid Cancer. Boston, MA: Kluwer Academic Publishers, 1998;27-57.
48. Goldman M. The Russian radiation legacy: its integrated impact and lessons. Environ Health Perspect 1997;105 Suppl 6:1385-1391.
49. Becker DV, Zanzonico P. Potassium iodide for thyroid blockade in a reactor accident. Administrative policies that govern its use. Thyroid 1997;7:193-197.
50. Baverstock K. Guidelines for Iodine Prophylaxis Following Nuclear Accidents. World Health Organization, Geneva 1999.
51. Nauman J, Wolff J. Iodide prophylaxis in Poland after the Chernobyl reactor accident. Benefits and risks. Am J Med 1993;94:524-532.
52. Ezzat S, Sarti DA, Cain DR, Braunstein GD. Thyroid incidentalomas - Prevalence by palpation and ultrasonography. Arch Intern Med 1994;154:1838-1840.
53. Tan GH, Ghanb H, Reading CC. Solitary thyroid nodule-Comparison between palpation and ultrasonography. Arch Intern Med 1995;155:2418-2423.
54. Schneider AB, Bekerman C, Leland J, et al. Thyroid nodules in the follow-up of irradiated individuals. Comparison of thyroid ultrasound with scanning and palpation. J Clin Endocrinol Metab 1997;82:4020-4027.
55. National Research Council and Institute of Medicine. Exposure of the American People to Iodine-131 From Nevada Nuclear-bomb Tests. Review of the National Cancer Institute Report and Public Health Implications, Washington, DC: National Academy Press, 1999.
56. Gharib H, Mazzafern EL. Thyroxine suppressive therapy in patients with nodular thyroid disease. Ann Intern Med 1998;128:386-394.
57. Schneider AB. Cancer therapy and endocrine disease: Radiation-induced thyroid tumours. In: Sheaves R, Jenkins PJ, Wass JA, eds. Clinical endocrine oncology. Oxford: Blackwell Science, 1997;514-517.